Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM Contracts Should Focus On Net Cost, Not Rebates, Express Scripts Says

Executive Summary

Drug plans should focus on PBMs' abilities to lower overall net cost of prescriptions, rather than try to get a share of manufacturer rebates, Express Scripts Senior VP Thomas Boudreau told a Federal Trade Commission hearing on health care competition June 26 in Washington, D.C
Advertisement

Related Content

Generics Last? Medco Accused Of Shifting Away From Mature Brands
IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says
IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says
Advertisement
UsernamePublicRestriction

Register

PS042102

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel